Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study

AIM To assess the value of microalbuminuria as an indicator of increased cardiovascular risk in a non-diabetic population. METHODS AND RESULTS 7579 non-diabetic subjects were studied with ages ranging from 28 to 75 years selected from a population based cohort. Using computerized Minnesota coding, ischaemic electrocardiographic abnormalities were divided into three categories: infarct patterns, major ischaemia, and minor ischaemia. Urinary albumin excretion was measured as the mean of two 24-h urine collections. Cardiovascular risk indicators were defined as an age above 60 years, male sex, hypertension, hypercholesterolaemia, smoking, obesity and a positive cardiovascular family history. Microalbuminuria was associated with age, sex, blood pressure, serum cholesterol, serum glucose, body mass index and all three categories of electrocardiographic abnormalities. In a multivariate model, adjusted for established cardiovascular risk indicators, microalbuminuria was independently associated with infarct patterns (OR [95% CI] 1.61 [1.12-2.32]), major ischaemia (OR 1.43 [1.08-1.91]) and minor ischaemia (OR 1.32 [1.03-1.68]). CONCLUSIONS The independent association between microalbuminuria and ischaemic electrocardiographic abnormalities suggests that microalbuminuria has additional value to conventional risk indicators in predicting cardiovascular disease in non-diabetics. Assessment of microalbuminuria could be an instrument to identify those at an increased risk for coronary vascular disease in an early stage.

[1]  A. Hoes,et al.  Diagnostic interpretation of electrocardiograms in population-based research: computer program research physicians, or cardiologists? , 1997, Journal of clinical epidemiology.

[2]  K. Borch-Johnsen,et al.  Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.

[3]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[4]  R. Knapp,et al.  Electrocardiographic Abnormalities and 30‐Year Mortality Among White and Black Men of the Charleston Heart Study , 1993, Circulation.

[5]  G. Pagano,et al.  PAI-1 and Factor VII Activity Are Higher in IDDM Patients With Microalbuminuria , 1994, Diabetes.

[6]  R F Heller,et al.  How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. , 1984, British medical journal.

[7]  M. Cirillo,et al.  Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. , 1998, Archives of internal medicine.

[8]  S. Yusuf,et al.  Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE Study , 1996, Diabetes Care.

[9]  N. Stenhouse,et al.  Electrocardiograms and 13 year cardiovascular mortality in Busselton study. , 1982, British heart journal.

[10]  W. Kannel,et al.  Parental history is an independent risk factor for coronary artery disease: the Framingham Study. , 1990, American heart journal.

[11]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[12]  H. Krumholz,et al.  Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. , 1997, Circulation.

[13]  A. Donker,et al.  Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM , 1995, Diabetes.

[14]  J A Kors,et al.  Validation of a new computer program for Minnesota coding. , 1996, Journal of electrocardiology.

[15]  J Pekkanen,et al.  Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. , 1996, Circulation.

[16]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[17]  H. Yokoyama,et al.  Immunohistochemical Quantification of Heparan Sulfate Proteoglycan and Collagen IV in Skeletal Muscle Capillary Basement Membranes of Patients With Diabetic Nephropathy , 1997, Diabetes.

[18]  J. L. Willems,et al.  The Diagnostic Performance of Computer Programs for the Interpretation of Electrocardiograms , 1991 .

[19]  M C Hjortland,et al.  Predicting coronary heart disease in middle-aged and older persons. The Framington study. , 1977, JAMA.

[20]  F. Luft,et al.  Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension , 1996, Journal of hypertension.

[21]  H. Tyroler,et al.  Incidence of coronary heart disease by ethnic group, social class, and sex. , 1971, Archives of internal medicine.

[22]  M. Muggeo,et al.  Noninvasive Detection of Functional Alterations of the Arterial Wall in IDDM Patients With and Without Microalbuminuria , 1995, Diabetes Care.

[23]  D. Reed,et al.  The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. , 1988, Journal of clinical epidemiology.

[24]  H. Parving,et al.  Prevention of diabetic renal disease with special reference to microalbuminuria , 1995, The Lancet.

[25]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[26]  P. Metcalf,et al.  Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. , 1992, Clinical chemistry.

[27]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[28]  A. Fitzgerald,et al.  Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.

[29]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[30]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[31]  R. Rosenberg,et al.  Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth , 1981, The Journal of cell biology.

[32]  S. Haffner,et al.  Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? , 1990, Arteriosclerosis.